Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Today St. Kitts & Nevis.
Press releases published on June 12, 2025
Celldex Presents Unprecedented 76 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI Congress 2025
GlobeNewswire
·
June 12, 2025
Seven months after the completion of dosing: 41% of patients (150 mg Q4W) continue to experience complete response (UAS7=0) 48% of patients (150 mg Q4W) report that CSU no longer impacts their quality of life (DLQI=0/1) KIT related tolerability events …
Daré Bioscience Announces Adjournment of Annual Meeting of Stockholders
GlobeNewswire
·
June 12, 2025
SAN DIEGO, June 12, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company driven by a mission to challenge the status quo, making women's health a priority, today announced that the company’s 2025 annual meeting of …
Hapbee Is Upgrading U.S. Listing to OTCID to Expand Investor Access and Increase Market Visibility
GlobeNewswire
·
June 12, 2025
VANCOUVER, British Columbia, June 12, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies Inc. (TSXV: HAPB | OTC: HAPBF) (“Hapbee” or the “Company”), a leading wearable wellness technology company, is pleased to announce that its U.S. listing has been upgraded …
Banner Health’s clinical leader driving care innovation
GlobeNewswire
·
June 12, 2025
PHOENIX, June 12, 2025 (GLOBE NEWSWIRE) -- Marjorie Bessel, MD, chief clinical officer at Banner Health, has been recognized as one of Modern Healthcare’s 50 Most Influential Clinical Executives for 2025. It is the third time in five years she has won this …
DBV Technologies participera au prochain congrès EAACI 2025
GlobeNewswire
·
June 12, 2025
Châtillon, France, le 12 juin (22:30 CEST) 2025 DBV Technologies participera au prochain congrès EAACI 2025 DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market: DBVT ; CUSIP : 23306J309), une société biopharmaceutique en phase …
DBV Technologies to Participate in Upcoming EAACI Congress 2025
GlobeNewswire
·
June 12, 2025
Châtillon, France, June 12, 2025 DBV Technologies to Participate in Upcoming EAACI Congress 2025 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharmaceutical company, today …
FibroGen Announces 1-for-25 Reverse Stock Split
GlobeNewswire
·
June 12, 2025
SAN FRANCISCO, June 12, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that it will implement a 1-for-25 reverse stock split of its issued and outstanding common stock ("Reverse Stock Split"), effective at 5:00 p.m. Eastern Time on …
Galapagos to Present New ATALANTA-1 CAR-T Data at EHA 2025, Highlighting Low Toxicity and Rapid, Decentralized Delivery of Fresh, Early-Memory-Enriched GLPG5101 in R/R NHL
GlobeNewswire
·
June 12, 2025
Data reported from the ongoing ATALANTA-1 Phase 1/2 study in a heavily pretreated relapsed refractory non-Hodgkin’s Lymphoma (R/R NHL) patient population demonstrate low rates of high-grade toxicities Of the 64 patients enrolled, 61 received treatment, …
Galapagos zal nieuwe ATALANTA-1 CAR-T data presenteren op EHA 2025, met lage toxiciteit en snelle, gedecentraliseerde toediening van vers, early-memory-verrijkt GLPG5101 bij R/R NHL
GlobeNewswire
·
June 12, 2025
Gegevens uit de lopende ATALANTA-1 fase 1/2-studie bij een zwaar voorbehandelde patiëntengroep met recidief/refractair non-Hodgkinlymfoom (R/R NHL) tonen lage percentages van hooggradige toxiciteiten aan Van de 64 ingeschreven patiënten werden er 61 …
Starton Therapeutics Announces Phase 2a Clinical Trial for Continuous Low-Dose Lenalidomide (STAR-LLD) in Multiple Myeloma Open for Enrollment
GlobeNewswire
·
June 12, 2025
Gabrail Cancer …
Centurion Service Group to auction all assets following the closure of Rockledge Hospital in Rockledge, FL
GlobeNewswire
·
June 12, 2025
Franklin Park, Illinois, June 12, 2025 (GLOBE NEWSWIRE) -- Centurion Service Group, an industry-leading medical equipment life-cycle company, has been selected to auction all medical and non-medical assets of Rockledge Hospital in Rockledge, FL. All …
Catheter Precision, Inc. Comments on Recent Market Activity
GlobeNewswire
·
June 12, 2025
FORT MILL, S.C., June 12, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, is issuing this press release in response to recent increases in …
Giant-Cell Arteritis Market Heats up with AbbVie’s RINVOQ Approval | DelveInsight
GlobeNewswire
·
June 12, 2025
New York, USA, June 12, 2025 (GLOBE NEWSWIRE) -- Giant-cell Arteritis Market Heats up with AbbVie’s RINVOQ Approval | DelveInsight The FDA has approved AbbVie’s RINVOQ (upadacitinib) for the treatment of giant cell arteritis, making it the ninth approved …
First of Its Kind in the Region: KFSHRC Successfully Performs Endoscopic Sleeve Gastroplasty on Kidney Transplant Patient
GlobeNewswire
·
June 12, 2025
RIYADH, Saudi Arabia, June 12, 2025 (GLOBE NEWSWIRE) -- In a medical achievement considered the first of its kind in the region, King Faisal Specialist Hospital …
Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 16, 2025, at 12:01 a.m., Eastern Time
GlobeNewswire
·
June 12, 2025
GAITHERSBURG, Md., June 12, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer …
Aptose Presents Safety, Response, and MRD Clinical Data from TUSCANY Phase 1/2 Clinical Trial of Tuspetinib Triplet Therapy in Newly Diagnosed AML at the 2025 EHA Congress
GlobeNewswire
·
June 12, 2025
Addition of TUS to standard of care VEN+AZA creates a well-tolerated and mutation agnostic frontline triple drug therapy for newly diagnosed AML AML patients with diverse mutations, including TP53-mutated/CK and FLT3-wildtype, safely achieved complete …
Apex Labs Granted Israel MoH Approval to Expand Phase 2b Macrodose Psilocybin PTSD Clinical Trial
GlobeNewswire
·
June 12, 2025
Israel’s Ministry of Health (MoH) approval to add additional sites to APEX SUMMIT-90 160 patient phase 2b macrodose clinical trial: Tel Aviv University (TAU)’s Institute for Psychedelic Research located at the Sagol Brain Institute (SGI) in Tel-Aviv …
Implantable Remote Patient Monitoring Devices Market to Grow 21.7% CAGR by 2029
GlobeNewswire
·
June 12, 2025
Boston, June 12, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Global Implantable Remote Patient Monitoring Devices Market” is expected to grow from $7.6 billion in 2024 to $20.3 billion by the end of 2029, at a compound …
Mama Bird Launches in Sprouts Farmers Market Nationwide With Brain-First Supplements for Families
GlobeNewswire
·
June 12, 2025
DENVER, June 12, 2025 (GLOBE NEWSWIRE) -- Mama Bird® is hatching at Sprouts this season! Mama Bird, maker of brain-boosting vitamins for families, is excited to announce that four of its best-selling prenatal and kids’ vitamins are now available at Sprouts …
Spark Biomedical Completes Enrollment in a Neurostimulation Pivotal Trial for Opioid Use Disorder
GlobeNewswire
·
June 12, 2025
Dallas, TX, June 12, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, a leader in wearable neurostimulation technology, has completed enrollment for its pivotal clinical trial, which aims to improve treatment retention for adults with opioid use disorder. Funded …